Clinical Trial Results:
A 26-week, randomised, open-label, multinational, treat-to-target trial comparing efficacy and safety of insulin degludec/insulin aspart (IDegAsp) twice daily (BID) and BIAsp 30 BID both with metformin in insulin naïve subjects with type 2 diabetes mellitus inadequately controlled on metformin monotherapy or metformin in combination with one additional oral antidiabetic drug (OAD).
Summary
|
|
EudraCT number |
2011-001712-61 |
Trial protocol |
DE BG PL CZ SK |
Global completion date |
19 Nov 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Jan 2016
|
First version publication date |
30 Jan 2016
|
Other versions |
|
Summary report(s) |
Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.